MoneyWorks4Me

Biocon informs about company updates

23 Jun 2017 Evaluate

In compliance with the provisions of Regulation 33(3)(b)(i) of SEBI (Listing Obligations and Disclosures Requirements)Regulations, 2015, Biocon has informed that the Company opts to submit quarterly/ year-to-date consolidated financial results in addition to submission of standalone financial results for the financial year 2017-18.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.40
Dr. Reddys Labs. 1197.40
Cipla 1332.90
Lupin 2014.75
Zydus Lifesciences 1145.50
View more..